Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorFudan University
About this trial
Real-world studies on long-term prognosis in patients who underwent anti-tumor treatments during hospitalization from a hospital-based cancer registry in china.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period.
Disqualifiers
Patients who have not been treated during hospitalization;
Patients with non-malignant tumors.
Trial population
All patients who completed tumor treatment (including surgery, radiotherapy, chemotherapy, immunotherapy, etc.) due to malignant tumors based on preoperative or intraoperative evaluation in Fudan University Shanghai Cancer Center during the study period.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
hospitalization
Procedure/SurgeryIncluding various treatments such as surgery, radiotherapy, chemotherapy and immunotherapy during hospitalization
Treatment groups
500,000 Participants
are divided into 1 treatment groupGroup A: All Cancers1 intervention
Trial outcomes
Primary outcomes
1
Overall survival
Death from any cause
Time frame
15 yearsSecondary outcomes
1
Disease-free survival
the time from treatment to recurrence of cancer, second primary cancer or death
Time frame
15 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov